Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.

J Bone Miner Res · 2013 · PMC3708101 · PMID 23322362

Europe PMC DOI

hedged sentences

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

showed a trendp = 0.098so close (0.05 < p ≤ 0.1)

Among microstructural variables, a statistically significant difference was observed for app.BS/BV ( p = 0.032) and app.BV/TV showed a trend ( p = 0.098), both in favor of teriparatide ( Table 3 , Fig. 4 ).

also in 53,322 other papers

borderline significantno p-value reported

Between-treatment differences in BV/TV were borderline significant, depending on the MMRM model (full or reduced) selected.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.